News Room

The company has received "Certificates of Pharmaceuticals Products" (COPP) for manufacturing facilities of following products in its exiting Multiple Purpose Plant conforming to the WHO guidelines:
(1) Ibuprofen IP/BP/USP/Ph.Eur./JP
(2) Lamotrigine IP/BP/USP/Ph.Eur.
from, Food & Drugs Administration, Punjab. This will facilitate the company to broaden its presence in export market.
Ibuprofen is, a non-steroidal anti-inflammatory drug (NSAID), used for the treatment of various types of pains and Lamotrigine is, an anti-convulsant drug, used for the treatment of epileptic seizures .
The company is already having US Food and Drug Administration (USFDA) and European Directorate for the Quality of Medicines & HealthCare (EDQM) approved Ibuprofen manufacturing facilities.